CN103877375B - 一种治疗封闭抗体缺乏型反复自然流产的中药及其制备方法 - Google Patents
一种治疗封闭抗体缺乏型反复自然流产的中药及其制备方法 Download PDFInfo
- Publication number
- CN103877375B CN103877375B CN201410086249.9A CN201410086249A CN103877375B CN 103877375 B CN103877375 B CN 103877375B CN 201410086249 A CN201410086249 A CN 201410086249A CN 103877375 B CN103877375 B CN 103877375B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- parched
- blocking antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 68
- 208000000995 spontaneous abortion Diseases 0.000 title claims abstract description 31
- 206010000234 Abortion spontaneous Diseases 0.000 title claims abstract description 30
- 230000000903 blocking effect Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 230000002950 deficient Effects 0.000 title abstract description 8
- 208000035999 Recurrence Diseases 0.000 title abstract 3
- 210000000582 semen Anatomy 0.000 claims abstract description 30
- 210000002826 placenta Anatomy 0.000 claims abstract description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 241000005787 Cistanche Species 0.000 claims abstract description 16
- 230000000306 recurrent effect Effects 0.000 claims description 22
- 241000208340 Araliaceae Species 0.000 claims description 17
- 239000009636 Huang Qi Substances 0.000 claims description 17
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 15
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 31
- 210000004369 blood Anatomy 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 24
- 230000035935 pregnancy Effects 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 4
- 208000023275 Autoimmune disease Diseases 0.000 abstract description 3
- 208000003441 Transfusion reaction Diseases 0.000 abstract description 3
- 208000024908 graft versus host disease Diseases 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000282994 Cervidae Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 241000804384 Cynomorium songaricum Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 241000347881 Kadua laxiflora Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000005713 exacerbation Effects 0.000 abstract 1
- 230000005284 excitation Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000020234 walnut Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 13
- 238000011160 research Methods 0.000 description 12
- 230000036039 immunity Effects 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 210000004698 lymphocyte Anatomy 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 238000009169 immunotherapy Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000003442 weekly effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000015994 miscarriage Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000008093 supporting effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 230000007365 immunoregulation Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940015047 chorionic gonadotropin Drugs 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000007368 endocrine function Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 208000013210 hematogenous Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 208000011726 slow pulse Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000206 ABO incompatibility Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000007190 Chlamydia Infections Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000710799 Rubella virus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003302 anti-idiotype Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000469 anti-sperm effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 235000019600 saltiness Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
Description
Claims (4)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510101071.5A CN104645030B (zh) | 2014-03-11 | 2014-03-11 | 治疗封闭抗体缺乏型反复自然流产的中药 |
CN201410086249.9A CN103877375B (zh) | 2014-03-11 | 2014-03-11 | 一种治疗封闭抗体缺乏型反复自然流产的中药及其制备方法 |
CN201510101257.0A CN104740299B (zh) | 2014-03-11 | 2014-03-11 | 一种治疗封闭抗体缺乏型反复自然流产的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410086249.9A CN103877375B (zh) | 2014-03-11 | 2014-03-11 | 一种治疗封闭抗体缺乏型反复自然流产的中药及其制备方法 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510101257.0A Division CN104740299B (zh) | 2014-03-11 | 2014-03-11 | 一种治疗封闭抗体缺乏型反复自然流产的中药 |
CN201510101071.5A Division CN104645030B (zh) | 2014-03-11 | 2014-03-11 | 治疗封闭抗体缺乏型反复自然流产的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103877375A CN103877375A (zh) | 2014-06-25 |
CN103877375B true CN103877375B (zh) | 2015-04-01 |
Family
ID=50946711
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510101257.0A Expired - Fee Related CN104740299B (zh) | 2014-03-11 | 2014-03-11 | 一种治疗封闭抗体缺乏型反复自然流产的中药 |
CN201410086249.9A Expired - Fee Related CN103877375B (zh) | 2014-03-11 | 2014-03-11 | 一种治疗封闭抗体缺乏型反复自然流产的中药及其制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510101257.0A Expired - Fee Related CN104740299B (zh) | 2014-03-11 | 2014-03-11 | 一种治疗封闭抗体缺乏型反复自然流产的中药 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN104740299B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104127562A (zh) * | 2014-07-31 | 2014-11-05 | 彭青 | 治疗复发性流产的天然药物组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103055042A (zh) * | 2013-01-17 | 2013-04-24 | 王彦菊 | 一种治疗习惯性流产的中药组合物及其制备方法 |
CN103341017A (zh) * | 2013-07-23 | 2013-10-09 | 黄淑娟 | 一种治疗习惯性流产的中药组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7410657B2 (en) * | 2004-09-30 | 2008-08-12 | Ai Ja Lee | Alternative remedy-based composition for enhancing fertility |
CN103156981B (zh) * | 2011-12-15 | 2015-04-15 | 赵子山 | 治疗子宫发育不良的中药组合物及其制备方法和应用 |
CN103611138B (zh) * | 2013-12-11 | 2015-06-17 | 杜满云 | 温宫种子丸 |
-
2014
- 2014-03-11 CN CN201510101257.0A patent/CN104740299B/zh not_active Expired - Fee Related
- 2014-03-11 CN CN201410086249.9A patent/CN103877375B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103055042A (zh) * | 2013-01-17 | 2013-04-24 | 王彦菊 | 一种治疗习惯性流产的中药组合物及其制备方法 |
CN103341017A (zh) * | 2013-07-23 | 2013-10-09 | 黄淑娟 | 一种治疗习惯性流产的中药组合物 |
Non-Patent Citations (1)
Title |
---|
中药保胎方配合孕酮治疗180例习惯性流产临床体会;贾立新;《中国现代药物应用》;20090310;第3卷(第05期);127-128 * |
Also Published As
Publication number | Publication date |
---|---|
CN103877375A (zh) | 2014-06-25 |
CN104740299B (zh) | 2018-02-27 |
CN104740299A (zh) | 2015-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103721045B (zh) | 用于提高肉鸡在生长过程中的免疫功能的中药免疫增强剂 | |
CN102327390A (zh) | 一种防治化疗毒副反应的中药组方及其丸剂的制备方法 | |
CN104922543A (zh) | 一种治疗闭经的药物组合物及其制备方法 | |
CN104352776A (zh) | 一种治疗月经过少致不孕的中药制剂及其制备方法 | |
CN101507776B (zh) | 一种治疗肾虚、腰膝酸软的中药制剂及其制备方法 | |
CN106214932A (zh) | 一种用于治疗肾阳虚衰及气虚血亏的中药组合物 | |
CN105497261A (zh) | 一种外用贴剂基质及该基质制成的外用贴剂和助眠贴 | |
CN104800720A (zh) | 用于改善种公牛性欲提高精液产量的药物及制备方法 | |
CN104587188A (zh) | 治疗卵巢早衰的中药配方 | |
CN101062193B (zh) | 补肾壮阳保健酒 | |
CN103877375B (zh) | 一种治疗封闭抗体缺乏型反复自然流产的中药及其制备方法 | |
CN101129763A (zh) | 治疗产后缺乳的一种中成药 | |
CN101129764A (zh) | 一种治疗产后缺乳的中成药 | |
CN106362120A (zh) | 一种治疗高血糖和糖尿病的中药方剂 | |
CN106361981A (zh) | 一种滋阴壮阳的中药 | |
CN105853867A (zh) | 一种治疗肾阳不足和气血两虚的药物组合物 | |
CN105362682A (zh) | 一种治疗月经过少的外用药物 | |
CN104306583A (zh) | 一种治疗月经量少的中药组合物及其制备方法 | |
CN101129584A (zh) | 治疗产后缺乳的一种中药制剂 | |
CN104645030A (zh) | 治疗封闭抗体缺乏型反复自然流产的中药 | |
CN114712470B (zh) | 一种治疗男士肾亏的药物及其制备方法 | |
CN105998532A (zh) | 治疗气滞血瘀型足跟痛的中药制备方法及其组合物 | |
CN101507797A (zh) | 一种治疗脱发的药酒 | |
CN101129702A (zh) | 一种治疗子宫脱垂的中药组合物 | |
CN105748735A (zh) | 一种治疗卵巢囊肿的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: WEIFANG MEDICAL COLLEGE Free format text: FORMER OWNER: TAO ENXUE Effective date: 20150209 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Tao Enxue Inventor before: Tao Enxue Inventor before: Gao Hanyi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: TAO ENXUE GAO HANYI TO: TAO ENXUE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150209 Address after: 261053 Shandong Province, Weifang city Weicheng District Baotong Street No. 7166 Weifang Medical University Applicant after: Weifang Medical University Address before: 261053 Shandong Province, Weifang city Weicheng District Baotong Street No. 7166 Weifang Medical University Applicant before: Tao Enxue |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150401 Termination date: 20210311 |
|
CF01 | Termination of patent right due to non-payment of annual fee |